Biohaven has a 1 year low of $26.80 and a ... The company's pipeline products include Troriluzole, which is in Phase 3 clinical trial for the treatment of neurological and neuropsychiatric ...

NEW YORK, NY / ACCESS Newswire / March 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Biohaven Ltd. ("Biohaven Ltd.") (NYSE:BHVN) concerning possible ...

After hours: March 18 at 6:07:31 PM EDT Loading Chart for BHVN ...

After hours: 7:57:59 pm GMT-5 ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.